India's Covaxin vaccine can neutralise the 617 variant: Top US health expert

Covaxin, India's home-grown COVID-19 vaccine, has been found to neutralise the 617 variant of the deadly virus, top US health expert Anthony Fauci has said. "So, despite the real difficulty that we're seeing in India, vaccination could be a very, very important antidote against this," he added. Covaxin has been developed by Bharat Biotech.